This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Specific developmental disorder of motor function
F5_MOTOR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
652 |
4. Check minimum number of eventsNone |
652 |
5. Include endpointsNone |
652 |
6. Filter based on genotype QC (FinnGen only) |
574 |
Control definitions (FinnGen only)
- Control exclude
- F5_PSYCHDEV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F80-F89
- Name in latin
- Perturbatio specifica progressus functionis motoricae
Similar endpoints
↥List of similar endpoints to
Specific developmental disorder of motor function
based on the number of shared cases.
Similar with more cases:
- Motor disorders
- Motor disorders, excluding more controls
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 574 | 239 | 335 |
| Unadjusted period prevalence (%) | 0.12 | 0.08 | 0.15 |
| Median age at first event (years) | 6.11 | 6.06 | 6.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 624
- Matched controls
- 6065
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
16384.0
307.7
588
*
R62.0
ICD-10 Finland
Delayed milestone
22.8
187.9
150
83
F83
ICD-10 Finland
Mixed specific developmental disorders
1128.9
181.1
170
*
XA800
NOMESCO Finland
Neuropsychological investigation
16.7
177.7
169
132
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
21.5
166.1
135
77
Z2445
NOMESCO Finland
Psychologist
8.4
121.6
197
315
R4120
NOMESCO Finland
Occupational therapy
11.2
116.4
139
151
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.6
115.3
158
206
F80.1
ICD-10 Finland
Expressive language disorder
267.5
112.6
113
5
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.8
96.0
188
361
Z3226
NOMESCO Finland
Physiotherapist
5.3
87.6
262
733
F80.2
ICD-10 Finland
Receptive language disorder
188.2
81.4
84
5
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
49.3
78.4
47
10
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
384.7
71.4
71
*
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
155.4
67.7
71
5
RT150, ,
NOMESCO Finland
20.3
65.4
52
27
RL140, ,
NOMESCO Finland
25.3
63.4
46
19
F81.0
ICD-10 Finland
Specific reading disorder
28.7
63.4
44
16
Z2446
NOMESCO Finland
Social worker
4.7
63.3
190
517
RL130, ,
NOMESCO Finland
21.8
54.6
42
20
R4110
NOMESCO Finland
Physiotherapy
3.7
53.7
250
920
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.3
53.1
100
179
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.9
52.9
89
142
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.2
52.5
181
540
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
49.4
213
739
N05AX08
ATC
risperidone; systemic
6.4
49.1
89
153
Z2221
NOMESCO Finland
Medical doctor
3.5
47.7
236
892
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.2
47.7
160
465
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
47.5
201
686
RT160, ,
NOMESCO Finland
14.9
46.5
43
30
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
44.8
252
1025
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
44.5
126
321
R1260
NOMESCO Finland
Evaluation of communicative skills
14.8
43.2
40
28
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.7
43.0
179
600
Z3231
NOMESCO Finland
Registered nurse
3.1
42.9
305
1415
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
98.7
42.9
47
5
R1250
NOMESCO Finland
Evaluation of functional capability
15.9
41.6
37
24
Z50.5
ICD-10 Finland
Speech therapy
5.9
41.2
81
150
R4130
NOMESCO Finland
Speech therapy
8.4
40.1
55
69
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
39.6
38
*
R5599
NOMESCO Finland
Other rehabilitation service
8.6
39.4
53
65
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.5
39.2
110
277
ZXE20
NOMESCO Finland
More than three and less than five hours
4.3
38.6
117
312
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
106.5
37.7
41
*
ZY010
NOMESCO Finland
Hospital outpatient
4.1
37.6
121
337
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.2
37.0
115
312
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.7
36.9
75
143
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.7
36.7
96
228
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
36.7
282
1339
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
14.5
36.4
34
24
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.0
35.7
68
122
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.8
33.8
66
121
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
33.0
204
852
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.2
32.9
99
261
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.1
32.2
74
157
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.3
32.1
69
138
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.1
31.7
99
268
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.8
30.7
107
313
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
112.7
30.6
33
*
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.0
30.4
36
37
Z31.5
ICD-10 Finland
Genetic counselling
4.0
30.4
96
262
602
Kela drug reimbursment
Children's severe malnutrition
5.3
30.2
65
130
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.6
29.2
49
77
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.7
29.0
42
56
N05AH03
ATC
olanzapine; systemic
4.1
27.8
83
217
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.0
27.8
63
132
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
29.3
27.5
37
13
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
27.5
158
627
A28
ICPC
Limited function/disability NOS
4.4
27.2
74
180
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.1
27.1
82
216
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.6
27.1
102
313
F84.5
ICD-10 Finland
Asperger syndrome
42.3
26.7
33
8
N06BA04
ATC
methylphenidate; oral
3.1
26.3
131
478
N03AG01
ATC
valproic acid; systemic, rectal
4.4
25.0
67
161
RS222, ,
NOMESCO Finland
8.3
25.0
34
42
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
24.9
24
*
ZXE00
NOMESCO Finland
One hour or less
2.4
24.7
287
1590
P07.2
ICD-10 Finland
Extreme immaturity
71.0
24.7
28
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.5
24.3
95
298
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.1
24.2
44
75
P85
ICPC
Mental retardation
8.8
23.9
31
36
N05AX12
ATC
aripiprazole; systemic
4.1
23.9
70
180
F88
ICD-10 Finland
Other disorders of psychological development
33.9
23.2
30
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
23.0
139
562
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.1
22.9
67
172
XX4AW, ,
NOMESCO Finland
6.1
22.8
41
69
N03AX14
ATC
levetiracetam; systemic
6.1
22.8
41
69
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.4
22.0
90
290
F20.9
ICD-10 Finland
Schizophrenia, unspecified
8.6
21.3
28
33
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
21.2
145
622
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
26.8
21.2
29
11
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.3
20.8
28
34
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
7.3
20.6
31
43
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
20.3
230
1237
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
42.0
20.3
25
6
H01AC01
ATC
somatropin; parenteral
4.6
20.3
50
112
ZXA00
NOMESCO Finland
Right side
2.9
19.5
105
396
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
19.5
145
645
F93.89
ICD-10 Finland
Other childhood emotional disorders
4.3
19.3
52
125
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.6
19.1
68
200
N05AH02
ATC
clozapine; systemic
6.7
19.0
31
47
H52.2
ICD-10 Finland
Astigmatism
4.1
18.9
55
140
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
18.9
111
439
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
5.3
18.6
39
76
K03.66
ICD-10 Finland
Tooth plaque
2.5
18.5
147
673
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.3
18.4
74
235
N05BA09
ATC
clobazam; oral
6.6
18.2
30
46
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
17.7
90
329
N05AH04
ATC
quetiapine; oral
2.4
17.6
142
654
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
17.4
205
1108
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
18.8
17.2
26
14
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
6.8
16.9
27
40
RS211, ,
NOMESCO Finland
7.4
16.9
25
34
RS220, ,
NOMESCO Finland
5.7
16.8
32
57
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.6
16.6
41
92
IGV01
NOMESCO Finland
Psychiatric network contact
4.3
16.5
44
105
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
7.2
16.5
25
35
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.4
16.3
64
200
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.5
16.2
58
171
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
16.0
68
223
C03CA01
ATC
furosemide; systemic
4.2
15.9
44
108
RF120, ,
NOMESCO Finland
13.7
15.8
27
20
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
15.8
58
174
N05CD08
ATC
midazolam; nasal, systemic
4.4
15.7
40
92
SPAT1229
SPAT
Assessment of need for aid
6.8
15.7
25
37
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.9
15.5
48
128
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
5.7
15.4
29
51
WX882
NOMESCO Finland
High dependency care
2.7
15.3
88
342
F89
ICD-10 Finland
Unspecified disorder of psychological development
38.0
15.2
19
5
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
15.0
59
185
FM2CE, ,
NOMESCO Finland
3.0
14.9
72
255
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
14.8
73
261
R5140
NOMESCO Finland
Monitoring the use of the aid
4.8
14.7
34
72
WX730
NOMESCO Finland
Conventional respirator
12.5
14.7
26
21
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.3
14.7
57
177
WX722
NOMESCO Finland
PEEP
4.4
14.5
37
85
F84.0
ICD-10 Finland
Childhood autism
+∞
14.5
14
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.7
14.2
27
48
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
14.1
114
521
N03AX09
ATC
lamotrigine; oral
3.4
14.1
52
156
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.4
14.1
36
83
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.4
14.0
28
52
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.6
14.0
34
75
H50.31
ICD-10 Finland
Intermittent exotropia
4.7
14.0
33
71
IGP01
NOMESCO Finland
Psychiatric family contact
3.3
14.0
56
177
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.9
14.0
22
32
H50.30
ICD-10 Finland
Intermittent esotropy
5.2
13.9
29
56
RD210, ,
NOMESCO Finland
3.1
13.8
62
210
N05AA02
ATC
levomepromazine; systemic
5.4
13.6
27
50
ZXA05
NOMESCO Finland
Left side
2.5
13.5
90
377
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
16.2
13.3
21
13
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
13.3
126
617
301
Kela drug reimbursment
Growth hormone
5.7
13.2
25
44
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
6.5
13.2
22
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
13.2
149
782
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
13.1
93
400
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.5
13.0
86
358
AA1AD
NOMESCO Finland
CT of head and brain
2.6
12.9
81
329
H50.0
ICD-10 Finland
Convergent concomitant strabismus
4.6
12.9
31
68
RT490, ,
NOMESCO Finland
16.7
12.8
20
12
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.7
12.8
75
294
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.0
12.7
28
57
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
12.5
76
304
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
12.5
53
174
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
12.4
31
70
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
12.4
12
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
17.3
12.4
19
11
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
4.2
12.3
33
79
P24
ICPC
Specific learning problem
3.3
12.2
48
150
R11
ICD-10 Finland
Nausea and vomiting
2.3
12.1
97
441
183
Kela drug reimbursment
Lamotrigin and topiramate
9.0
12.1
25
28
H35.1
ICD-10 Finland
Retinopathy of prematurity
37.3
12.1
15
*
N03AF02
ATC
oxcarbazepine; oral
3.8
12.1
37
98
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
12.0
67
256
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.5
12.0
30
68
ZXD20
NOMESCO Finland
Day surgery
2.6
12.0
74
298
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.8
11.9
22
38
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
11.8
72
288
L02AE02
ATC
leuprorelin; implant, parenteral
8.9
11.6
24
27
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
11.6
40
115
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
29.8
11.5
15
5
ZXA10
NOMESCO Finland
Bilateral
2.1
11.3
116
583
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
34.7
11.1
14
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
11.1
71
290
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
9.6
11.1
22
23
T90
ICPC
Diabetes non-insulin dependent
3.5
11.0
39
114
RS312, ,
NOMESCO Finland
24.8
11.0
15
6
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
11.0
165
951
WX002
NOMESCO Finland
Sedation and analgesia
2.5
10.9
75
317
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.9
10.7
54
195
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
5.7
10.7
20
35
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.8
10.6
24
50
N05BA01
ATC
diazepam; systemic, rectal
2.9
10.5
52
186
RT422, ,
NOMESCO Finland
59.4
10.5
12
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.1
10.5
46
154
XCK00
NOMESCO Finland
Perimetry
5.1
10.4
22
43
DFF20
NOMESCO Finland
Audiometry for children
4.4
10.4
26
59
F80.0
ICD-10 Finland
Specific speech articulation disorder
5.5
10.3
20
36
ZXD05
NOMESCO Finland
Urgent procedure
1.9
10.3
149
846
IEV99
NOMESCO Finland
Other psychiatric network intervention
4.1
10.3
29
72
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.2
10.2
21
40
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
15.9
10.2
16
10
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.4
10.2
37
110
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
11.2
9.9
18
16
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.7
9.8
56
216
RF210, ,
NOMESCO Finland
4.6
9.7
23
50
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.0
9.6
27
67
DFF00
NOMESCO Finland
Pure tone audiometry
3.1
9.6
41
135
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
9.6
220
1438
SPAT1234
SPAT
Support of social functional capacity
4.1
9.6
26
63
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
54.3
9.6
11
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
13.3
9.5
16
12
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.9
9.5
28
72
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.6
9.5
59
238
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
14.9
9.4
15
10
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
9.4
52
198
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
7.1
9.4
22
31
R27.0
ICD-10 Finland
Ataxia, unspecified
98.7
9.3
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.3
9.2
35
107
XG413
NOMESCO Finland
Spirometry with oscillometry
3.6
9.2
31
88
RF420, ,
NOMESCO Finland
9.4
9.1
18
19
Q38.1
ICD-10 Finland
Ankyloglossia
3.7
9.1
29
79
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
9.1
39
129
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.2
9.1
24
57
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
9.0
30
84
EJC20
NOMESCO Finland
Operation on frenulum of tongue
4.3
9.0
23
53
G47.3
ICD-10 Finland
Sleep apnoea
2.5
9.0
58
238
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.4
9.0
32
94
RS120, ,
NOMESCO Finland
11.4
8.9
16
14
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.2
8.9
19
23
RT130, ,
NOMESCO Finland
15.4
8.9
14
9
P72
ICPC
Schizophrenia
7.0
8.9
21
30
C03DA01
ATC
spironolactone; oral
3.3
8.8
33
100
A03FA02
ATC
cisapride; oral, rectal
3.3
8.8
33
100
L28
ICPC
Limited function/disability (L)
2.6
8.7
53
212
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.3
8.6
70
319
XF404
NOMESCO Finland
Ambulatory ECG
2.8
8.6
44
161
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
4.6
8.5
20
43
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
3.8
8.5
26
69
RS122, ,
NOMESCO Finland
16.1
8.4
13
8
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
16.1
8.4
13
8
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
8.4
50
197
ZX114
NOMESCO Finland
Intramuscular
4.1
8.4
23
56
Z07
ICPC
Education problem
3.3
8.3
32
99
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
8.3
133
777
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
8.3
65
292
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
8.3
175
1110
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
8.2
35
115
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
7.8
8.2
18
23
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
4.0
8.2
23
57
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.6
8.2
48
188
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
8.2
50
200
K07.24
ICD-10 Finland
Open bite
2.9
8.2
39
137
EMB30
NOMESCO Finland
Adenotomy
1.9
8.2
123
704
RS140, ,
NOMESCO Finland
9.4
8.2
16
17
N28
ICPC
Limited function/disability (N)
9.4
8.2
16
17
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.3
8.1
21
49
BF20A, ,
NOMESCO Finland
14.3
8.1
13
9
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.5
8.0
18
24
P07.3
ICD-10 Finland
Other preterm infants
2.8
8.0
40
144
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
32.9
8.0
10
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
17.0
8.0
12
7
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
8.1
8.0
17
21
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.1
8.0
17
21
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.9
244
1705
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
7.9
36
123
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.2
7.9
32
102
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.4
7.9
28
82
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.7
7.9
25
68
H81
ICPC
Excessive ear wax
2.3
7.8
62
280
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
7.8
118
676
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.2
7.7
64
294
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.8
7.7
38
136
SPAT1262
SPAT
Handing over of treatment supplies
2.4
7.7
56
243
ZX108
NOMESCO Finland
Inhalation
6.0
7.7
20
33
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
7.7
33
109
OAA43, ,
SPAT
2.2
7.7
70
334
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
9.3
7.7
15
16
H52.0
ICD-10 Finland
Hypermetropia
2.6
7.7
43
165
TJD20
NOMESCO Finland
Change of gastrostomy tube
6.9
7.6
18
26
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
44.3
7.6
9
*
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
44.3
7.6
9
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
44.3
7.6
9
*
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
7.6
65
1193
N06BA09
ATC
atomoxetine; oral
4.4
7.6
19
43
RT420, ,
NOMESCO Finland
14.8
7.6
12
8
N05BA06
ATC
lorazepam; systemic, sublingual
6.3
7.6
19
30
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
7.5
83
426
N88
ICPC
Epilepsy
7.4
7.5
17
23
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
7.5
27
80
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.9
7.5
109
616
F81.1
ICD-10 Finland
Specific spelling disorder
24.6
7.5
10
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.9
7.5
16
20
E22.80
ICD-10 Finland
Central precocious puberty
11.7
7.5
13
11
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
11.7
7.5
13
11
B01AA03
ATC
warfarin; systemic
4.2
7.5
20
48
P99
ICPC
Psychological disorders other
3.0
7.4
32
106
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.8
7.4
37
134
H47.2
ICD-10 Finland
Optic atrophy
13.2
7.3
12
9
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
13.2
7.3
12
9
WX892
NOMESCO Finland
Monitored bed care
2.3
7.3
54
237
WX402
NOMESCO Finland
General anaesthesia
1.7
7.2
159
1014
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
7.2
7
*
RL710, ,
NOMESCO Finland
+∞
7.2
7
*
RT121, ,
NOMESCO Finland
+∞
7.2
7
*
N06AB10
ATC
escitalopram; oral
1.8
7.2
124
738
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
4.4
7.2
18
41
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.5
7.1
24
68
RF430, ,
NOMESCO Finland
15.5
7.1
11
7
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.4
7.1
49
208
RS231, ,
NOMESCO Finland
19.7
7.0
10
5
Z02.7
ICD-10 Finland
Issue of medical certificate
2.4
7.0
50
215
ZX120
NOMESCO Finland
Intravenous
2.3
7.0
55
247
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
4.1
7.0
19
46
RS311, ,
NOMESCO Finland
11.9
7.0
12
10
ZX199
NOMESCO Finland
Other rote
6.0
6.9
18
30
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
6.9
39
150
F40.2
ICD-10 Finland
Specific (isolated) phobias
4.4
6.9
17
38
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
4.4
6.9
17
38
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
6.9
111
646
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.9
6.9
20
51
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
2.9
6.8
31
106
OAB43, ,
SPAT
0.6
6.8
114
1710
WX704
NOMESCO Finland
Intubation
2.5
6.8
43
175
SPAT1389
SPAT
Visit based on need for special support
1.9
6.8
89
485
UKC02
NOMESCO Finland
Cystoscopy
3.0
6.8
30
101
A11CC03
ATC
alfacalcidol; systemic
3.6
6.8
22
61
SPAT1243
SPAT
Psychiatric/psychological examination
2.5
6.7
43
176
IEP03
NOMESCO Finland
Focused parental counselling
2.9
6.7
31
107
G91.1
ICD-10 Finland
Obstructive hydrocephalus
10.8
6.7
12
11
Q87.14
ICD-10 Finland
Noonan's syndrome
39.4
6.7
8
*
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
16.4
6.7
10
6
E34.31
ICD-10 Finland
Short stature, prenatal disorder
6.0
6.6
17
28
Z50.1
ICD-10 Finland
Other physical therapy
3.9
6.6
19
48
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
22.2
6.6
9
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.7
6.6
34
125
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.2
6.6
26
82
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
6.6
41
166
E34.35
ICD-10 Finland
Abnormal growth retardation
2.8
6.5
33
120
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
6.5
109
643
G40.89
ICD-10 Finland
Other epilepsy
9.9
6.4
12
12
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.7
6.4
20
54
TAB00
NOMESCO Finland
Lumbar puncture
2.6
6.4
36
139
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
6.1
6.3
16
26
SPAT1281
SPAT
Other administrative function
2.1
6.3
65
325
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.3
6.3
18
34
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
5.6
6.3
17
30
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.9
6.3
79
424
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.0
6.3
28
95
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
3.0
6.3
28
95
H03AA01
ATC
levothyroxine sodium; systemic
2.1
6.3
62
306
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
6.3
37
146
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
6.3
51
233
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.7
6.2
33
123
F91.9
ICD-10 Finland
Conduct disorder, unspecified
8.0
6.2
13
16
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.1
6.2
18
35
RL720, ,
NOMESCO Finland
+∞
6.2
6
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
9.1
6.2
12
13
RT190, ,
NOMESCO Finland
9.1
6.2
12
13
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.9
6.2
16
27
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
17.7
6.2
9
5
Q75.3
ICD-10 Finland
Macrocephaly
17.7
6.2
9
5
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
6.2
30
107
N06AB03
ATC
fluoxetine; oral
2.1
6.2
62
308
R32
ICD-10 Finland
Unspecified urinary incontinence
4.0
6.1
17
42
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.0
6.1
26
86
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
6.1
166
1115
NF1DA
NOMESCO Finland
X-ray of hips
6.2
6.0
15
24
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
2.6
6.0
34
131
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
3.3
6.0
22
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
346
1998
2.53
28.27
22.5
13.2
1.22
1.23
mmol/l
1.66
338
1913
356
2131
2.45
26.19
18.2
12.0
1.22
1.22
mmol/l
1.28
338
1973
412
2725
2.38
22.87
8.4
6.5
121.84
109.37
u/l
2.24
394
2594
31
42
7.50
21.04
22.2
30.3
1339.77
1250.43
nmol/l
0.27
31
42
257
1484
2.16
18.70
10.2
8.9
38.36
38.45
g/l
0.09
244
1432
29
42
6.99
18.55
17.3
22.5
18757.45
729.93
nmol/l
0.49
29
42
311
1957
2.09
17.81
5.3
3.7
67.49
66.25
nmol/l
0.36
301
1862
200
1065
2.21
17.67
3.3
3.0
2.38
2.39
mmol/l
1.24
190
992
281
1714
2.08
17.38
10.0
7.6
22.53
19.51
umol/l
0.52
266
1598
108
453
2.59
16.23
18.4
15.0
106.31
105.29
mmol/l
1.08
108
453
153
765
2.25
15.51
3.7
2.5
273.34
466.74
u/l
0.90
153
741
176
938
2.15
15.18
16.3
11.7
1.31
1.33
mmol/l
0.34
168
897
49
137
3.69
14.78
2.5
3.7
4.40
6.62
index
0.34
30
92
75
279
2.83
14.17
29.7
16.0
-0.62
-0.04
mmol/l
0.54
64
239
230
1406
1.93
13.26
5.6
4.8
39.28
32.72
u/l
0.60
225
1346
356
2514
1.88
13.05
14.7
7.9
5.98
6.13
mmol/l
0.57
340
2327
180
1025
1.99
12.67
11.2
10.3
0.73
1.09
mmol/l
0.77
149
846
535
4377
2.32
12.41
25.6
12.3
139.61
139.47
mmol/l
0.91
530
4262
535
4383
2.31
12.27
25.4
12.4
3.95
3.93
mmol/l
1.36
528
4243
40
111
3.67
12.20
3.8
4.8
1.51
1.69
umol/l
0.60
40
111
129
663
2.12
11.93
18.0
12.1
0.80
0.82
mmol/l
1.16
124
639
120
601
2.16
11.85
7.7
7.1
6.20
6.86
umol/l
0.22
105
493
402
3028
1.82
11.15
13.3
10.5
0.21
0.22
e9/l
0.41
365
2550
417
3183
1.82
10.99
16.2
11.7
3.63
3.61
e9/l
0.07
370
2633
159
910
1.94
10.81
4.7
3.9
4.43
1.88
e6/l
1.87
89
465
205
1276
1.84
10.73
4.5
5.0
8.08
9.04
mmol/l
1.37
187
1205
92
432
2.25
10.59
15.0
6.3
1146.40
1070.05
ng/l
0.05
72
347
457
3611
1.86
10.48
5.2
3.8
14.68
14.55
pmol/l
0.52
432
3304
119
630
2.03
10.05
4.1
3.2
2.62
2.53
g/l
1.00
109
606
125
674
2.00
10.03
4.1
3.2
12.49
14.27
umol/l
2.03
118
652
19
19
9.99
9.88
4.7
2.8
25.52
29.57
umol/l
0.57
19
19
179
1100
1.82
9.60
2.0
1.6
99.83
98.08
pmol/l
0.16
86
584
499
4106
1.90
9.40
5.8
4.3
2.01
1.90
mu/l
1.50
478
3889
87
424
2.16
9.10
2.9
2.2
4.42
5.70
u/l
1.57
62
268
53
210
2.59
8.84
38.9
18.0
93.75
95.39
%
0.40
53
210
52
205
2.60
8.76
39.4
18.4
0.60
0.68
%
1.06
52
205
234
1587
1.69
8.73
6.2
4.6
—
—
—
0
0
156
945
1.81
8.66
18.4
8.6
0.36
0.96
mmol/l
2.07
117
691
404
3172
1.67
8.42
4.4
2.5
5.71
5.39
mmol/l
3.12
385
2933
121
686
1.89
8.27
1.6
1.4
19.77
19.29
nmol/l
0.13
110
619
62
275
2.32
8.12
3.4
3.6
5.11
5.14
pmol/l
0.06
62
257
225
1540
1.66
7.94
6.0
4.3
10.28
41.34
e6/l
4.07
173
1141
149
915
1.77
7.82
4.9
3.7
0.50
0.78
e6/l
1.16
79
463
169
1079
1.72
7.72
3.9
3.2
—
—
—
0
0
550
4762
2.03
7.69
14.3
9.3
31.85
27.24
u/l
2.14
540
4635
11
6
18.10
7.50
1.0
1.0
—
—
—
0
0
172
1129
1.66
7.00
3.5
2.9
1.02
1.02
kg/l
0.95
115
666
47
198
2.41
6.92
1.9
1.9
21.95
26.74
ng/l
0.32
47
198
75
386
2.01
6.76
3.1
2.2
5.98
6.73
iu/l
0.39
53
246
139
876
1.70
6.55
18.2
8.5
9.65
9.79
kpa
0.36
134
853
41
167
2.48
6.49
13.0
11.6
22.76
23.37
mmol/l
0.74
41
158
103
597
1.81
6.49
5.6
3.2
778.92
1146.82
ng/l
0.50
68
308
384
3076
1.55
6.49
3.9
2.7
1.27
1.13
mmol/l
2.98
370
2942
377
3010
1.55
6.45
5.2
3.5
36.09
35.71
mmol/mol
0.27
368
2904
553
4860
1.93
6.44
18.0
10.4
60.45
63.60
umol/l
2.44
548
4775
130
808
1.71
6.43
7.3
4.4
1.19
1.56
mg/l
0.51
99
555
120
731
1.74
6.38
11.0
6.8
30.83
30.58
s
0.15
120
725
200
1408
1.56
5.95
6.0
4.2
0.14
0.25
e6/l
0.95
144
1009
88
501
1.82
5.86
2.8
2.2
10.02
11.56
nmol/l
0.68
83
463
15
26
5.72
5.72
2.1
1.5
0.16
0.30
iu/ml
—
10
16
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
95
2.84
5.69
33.4
23.1
0.32
0.33
iu/ml
0.29
17
57
99
590
1.75
5.66
1.5
1.5
216.47
419.22
u/ml
1.03
92
563
72
390
1.90
5.60
14.8
9.7
93.50
92.68
%
0.13
72
390
56
279
2.04
5.53
10.0
15.2
130.80
129.33
g/l
0.19
56
270
239
1778
1.50
5.40
4.6
3.4
—
—
estimate
—
0
0
146
976
1.59
5.36
4.5
3.4
8.11
7.15
e6/l
0.29
133
884
80
455
1.81
5.35
2.7
1.8
—
—
—
0
0
79
448
1.82
5.33
2.9
1.9
—
—
—
0
0
411
3413
1.50
5.31
4.5
3.1
4.28
4.40
mmol/l
1.98
397
3286
33
137
2.42
5.06
2.4
2.1
1.02
1.02
ratio
0.72
27
115
15
32
4.64
4.88
2.2
1.4
0.67
0.98
iu/ml
—
9
15
405
3385
1.46
4.81
4.5
3.0
2.65
2.68
mmol/l
0.35
393
3235
39
179
2.19
4.77
2.2
4.6
272.46
353.11
mg/l
1.40
39
174
48
240
2.02
4.72
10.4
14.8
0.63
0.60
%
0.21
48
240
187
1356
1.49
4.66
2.1
1.9
1.49
1.29
mmol/l
2.23
175
1255
52
270
1.95
4.60
1.6
1.8
—
—
—
0
0
539
4806
1.66
4.54
27.6
15.6
13.37
13.06
%
7.51
533
4745
32
139
2.30
4.46
3.4
3.1
657.79
539.05
e6/l
0.45
24
83
28
115
2.43
4.41
2.5
1.6
—
—
—
0
0
37
172
2.16
4.40
2.4
5.0
33.50
536.08
e6/l
1.15
28
115
401
3373
1.44
4.40
4.3
2.9
1.26
1.37
mmol/l
9.22
389
3227
71
414
1.75
4.37
2.2
2.0
2.41
2.41
mmol/l
0.12
58
362
37
173
2.15
4.34
2.3
4.9
8.88
5.96
e6/l
0.16
25
111
32
142
2.25
4.26
3.6
3.1
278.17
206.25
e6/l
0.47
24
87
37
176
2.11
4.16
3.4
2.0
—
—
—
0
0
30
132
2.27
4.08
9.2
5.4
88.80
98.51
%
1.24
30
132
330
2708
1.39
4.00
5.8
3.9
163.40
1792.38
e6/l
—
10
29
31
140
2.21
3.97
3.8
3.3
—
—
—
0
0
36
173
2.09
3.96
2.0
1.4
—
—
—
0
0
36
173
2.09
3.96
2.1
4.7
3.22
3.37
mmol/l
0.93
36
167
72
434
1.69
3.95
2.2
2.7
24.53
32.47
u/l
2.58
60
355
8
251
0.30
3.94
1.5
1.8
—
—
—
0
0
92
593
1.60
3.89
2.8
1.9
—
—
—
0
0
18
63
2.83
3.88
2.9
4.6
0.39
0.83
index
1.69
18
63
38
188
2.03
3.87
3.9
2.2
—
—
—
0
0
112
756
1.54
3.87
2.2
1.7
1.69
1.37
%
0.67
103
687
372
3134
1.38
3.74
11.0
7.2
112.39
109.75
ml/min/173m2
1.65
288
2466
41
214
1.92
3.61
4.7
3.5
—
—
—
0
0
26
114
2.27
3.59
3.1
1.8
—
—
—
0
0
282
2286
1.36
3.54
4.5
3.6
0.00
2.93
estimate
0.50
28
420
280
2272
1.36
3.47
4.5
3.6
0.00
0.00
estimate
-0.00
30
436
19
74
2.54
3.38
1.5
1.1
6.42
3.77
u/ml
0.21
12
31
27
124
2.17
3.35
2.6
1.9
—
—
—
0
0
212
2505
0.73
3.34
2.1
2.0
—
—
—
0
0
9
242
0.35
3.26
1.4
1.6
81.34
59.22
ug/l
—
9
242
280
2289
1.34
3.24
4.6
3.6
0.00
0.00
estimate
-0.00
28
419
35
181
1.93
3.19
13.7
11.4
1111.20
369.67
iu/ml
—
5
24
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
48
2.88
3.15
1.4
1.1
—
—
—
0
0
492
5106
0.70
3.14
3.8
3.9
—
—
—
0
0
10
24
4.10
3.11
3.7
2.3
13.79
13.82
umol/l
—
10
24
38
205
1.85
3.07
4.0
3.0
14.47
18.67
mu/l
0.84
38
195
27
130
2.06
3.00
2.7
1.8
—
—
—
0
0
109
772
1.45
2.97
3.0
2.3
59.42
66.29
ng/l
0.06
58
286
31
159
1.94
2.91
5.3
8.4
24.27
24.27
mmol/l
0.00
31
147
13
45
2.85
2.88
1.5
1.1
—
—
—
0
0
23
106
2.15
2.86
1.6
1.4
—
—
—
0
0
39
218
1.79
2.83
1.6
1.6
—
—
—
0
0
16
63
2.51
2.81
5.8
5.6
—
—
—
0
0
21
94
2.21
2.80
5.8
5.9
2.51
1.80
ug/l
0.61
21
94
10
27
3.64
2.80
3.8
6.8
151.60
214.55
ug/l
—
10
27
12
38
3.11
2.76
8.9
9.8
—
—
—
0
0
42
242
1.74
2.76
1.5
1.6
990.59
1098.48
nmol/l
0.33
32
191
17
70
2.40
2.73
1.1
1.2
94.35
109.45
%
0.73
17
65
166
1284
1.35
2.69
4.0
3.5
2.58
2.41
mg/l
0.61
151
1152
29
151
1.91
2.63
1.7
1.6
5.55
7.14
ug/l
0.32
29
142
12
42
2.81
2.62
1.2
1.1
—
—
—
0
0
11
265
0.39
2.59
1.7
1.7
—
—
—
0
0
16
67
2.36
2.49
21.6
9.3
9.87
8.51
mg/l
0.32
16
62
36
569
0.59
2.46
1.2
1.4
3.58
3.48
ratio
0.21
22
382
13
50
2.56
2.40
1.5
1.1
—
—
—
0
0
14
56
2.46
2.40
1.1
1.1
—
—
—
0
0
46
283
1.63
2.40
1.8
1.7
0.21
0.23
mg/l
0.14
19
138
19
88
2.13
2.37
1.1
1.1
—
—
—
0
0
26
138
1.87
2.26
2.3
1.6
—
—
—
0
0
12
46
2.57
2.24
1.2
1.1
—
—
—
0
0
17
77
2.18
2.24
42.9
34.2
158.59
141.43
ug/l
0.30
17
71
13
52
2.46
2.24
2.9
2.0
20.80
20.92
nmol/l
—
5
12
602
5678
1.87
2.22
30.5
17.0
268.08
266.07
e9/l
0.31
588
5470
6
13
4.52
2.22
3.7
2.9
—
—
—
0
0
18
334
0.51
2.16
1.7
1.7
—
—
—
0
0
13
53
2.41
2.16
2.8
2.0
164.23
125.53
%
0.97
13
53
38
571
0.62
2.13
1.4
1.5
—
—
—
0
0
602
5684
1.83
2.12
30.4
16.8
4.72
4.69
e12/l
0.76
584
5463
14
60
2.30
2.10
1.1
1.1
—
—
—
0
0
61
414
1.48
2.09
10.6
6.6
263.08
294.98
u/l
0.67
61
405
7
19
3.61
2.09
2.0
1.9
—
—
—
0
0
12
48
2.46
2.07
3.0
1.4
—
—
—
0
0
29
461
0.59
2.05
1.2
1.3
3.25
3.28
mmol/l
0.04
17
276
24
129
1.84
2.02
1.3
1.4
317.12
375.87
ug/g
0.82
17
67
543
5027
1.38
2.00
18.7
11.2
23.48
22.61
mg/l
0.23
443
3629
29
166
1.73
2.00
2.6
3.5
85.21
91.61
ml/min/173m2
—
7
49
19
95
1.97
1.97
4.5
2.4
1.73
2.31
mmol/l
0.56
11
77
13
56
2.28
1.93
1.0
1.1
—
—
—
0
0
10
38
2.58
1.93
26.2
9.1
1.21
1.24
mmol/l
—
10
33
19
96
1.95
1.92
2.9
1.5
—
—
—
0
0
7
21
3.26
1.91
1.0
1.6
—
—
—
0
0
27
154
1.74
1.90
1.4
1.3
—
—
—
0
0
27
154
1.74
1.90
1.4
1.3
—
—
—
0
0
38
555
0.64
1.89
1.5
1.7
1529.87
944.59
mu/l
0.41
29
507
151
1759
0.78
1.89
2.9
2.7
—
—
—
0
0
11
45
2.40
1.83
2.5
4.3
18.19
24.74
ug/l
1.33
11
45
32
194
1.64
1.81
1.3
1.1
—
—
—
0
0
17
85
1.97
1.78
2.0
1.5
—
—
—
0
0
12
52
2.27
1.77
10.3
11.1
—
569.30
—
0
10
71
513
1.39
1.77
4.3
4.9
5.60
41.16
mg/mmol
0.70
46
406
353
3125
1.23
1.74
5.5
4.5
8.25
6.85
mm/h
1.62
337
2934
9
35
2.52
1.74
1.7
1.2
672.11
388.01
mu/l
—
9
35
9
35
2.52
1.74
1.7
1.2
72.78
75.89
%
—
9
35
239
2035
1.23
1.71
2.0
1.7
1.68
1.68
g/l
0.01
124
1129
6
18
3.26
1.70
3.7
4.0
—
—
—
0
0
137
1098
1.27
1.68
4.0
3.6
0.00
0.00
estimate
0.50
29
407
20
109
1.81
1.65
1.6
1.5
—
—
—
0
0
11
48
2.25
1.61
6.5
7.8
—
—
—
0
0
5
14
3.49
1.57
1.4
1.2
13.20
9.64
mmol/l
—
5
14
8
32
2.45
1.54
1.1
1.1
—
—
—
0
0
10
44
2.23
1.44
4.8
5.5
5.38
4.86
kpa
—
10
44
147
1666
0.81
1.39
2.6
2.6
—
—
—
0
0
64
477
1.34
1.35
1.7
1.3
137.80
131.25
u/ml
0.04
12
157
6
23
2.55
1.32
1.0
1.3
108.83
105.30
%
—
6
23
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
60
1.96
1.29
3.1
2.1
138.83
120.57
%
0.38
12
60
19
111
1.68
1.28
5.1
10.1
65.76
507.10
mg/mmol
0.54
14
105
9
43
2.05
1.26
2.1
1.3
—
—
—
0
0
14
75
1.83
1.25
2.9
1.6
—
—
—
0
0
5
18
2.71
1.24
3.6
1.3
252.20
189.83
u/l
—
5
18
324
2905
1.17
1.22
6.4
4.2
36.03
28.29
u/l
1.91
319
2809
6
25
2.35
1.20
2.2
1.2
—
—
—
0
0
41
291
1.40
1.19
2.9
2.2
121.37
105.09
au/ml
0.35
19
111
8
37
2.12
1.18
3.1
1.8
102.00
97.43
g/l
—
8
37
20
123
1.60
1.13
3.9
5.0
8.09
11.08
u/ml
0.26
20
123
291
2598
1.17
1.13
4.4
3.6
62.17
59.40
ug/l
0.15
281
2483
22
140
1.55
1.09
2.2
2.2
2.23
3.97
iu/l
—
7
64
13
209
0.60
1.04
1.0
1.1
—
7.48
—
0
30
35
248
1.39
1.04
2.3
2.0
—
—
—
0
0
5
22
2.22
1.00
1.4
2.0
—
—
—
0
0
34
245
1.37
0.94
3.3
2.0
30.04
31.74
%
0.37
23
190
6
28
2.09
0.90
3.0
2.0
3.42
1.61
nmol/l
—
6
28
6
28
2.09
0.90
1.0
2.4
10.52
10.19
g/l
—
6
28
6
29
2.02
0.87
1.5
1.3
—
—
—
0
0
6
29
2.02
0.87
1.5
1.3
—
—
—
0
0
6
29
2.02
0.87
1.5
1.3
—
—
—
0
0
109
1214
0.85
0.85
3.6
2.8
0.00
0.00
estimate
0.50
20
359
6
110
0.53
0.84
1.7
1.9
—
—
—
0
0
6
31
1.89
0.82
1.0
2.3
2.65
3.03
g/l
—
6
31
6
31
1.89
0.82
1.0
2.3
4.48
4.11
g/l
—
6
31
6
31
1.89
0.82
1.0
2.3
7.63
7.30
g/l
—
6
31
6
31
1.89
0.82
1.0
2.3
3.37
3.65
g/l
—
6
31
11
171
0.62
0.80
1.8
1.7
14.87
10.27
u/ml
—
6
51
30
383
0.75
0.79
1.5
1.3
—
—
—
0
0
16
103
1.52
0.79
1.9
2.5
—
—
—
0
0
14
89
1.54
0.74
3.1
4.1
18.66
18.04
%
0.36
14
84
9
54
1.63
0.73
3.2
2.0
—
—
—
0
0
16
222
0.69
0.71
1.8
1.5
0.00
0.08
iu/ml
—
7
50
17
231
0.71
0.68
1.4
1.3
—
—
—
0
0
5
27
1.81
0.66
1.0
2.4
0.00
0.00
g/l
—
5
27
5
27
1.81
0.66
2.8
1.4
—
—
—
0
0
5
27
1.81
0.66
1.0
2.4
0.00
0.00
g/l
—
5
27
29
359
0.77
0.64
1.5
1.5
—
—
—
0
0
10
61
1.60
0.62
1.2
1.1
—
—
—
0
0
176
1574
1.12
0.62
3.7
3.1
0.00
0.01
estimate
0.80
22
370
17
118
1.41
0.61
1.1
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
32
386
0.80
0.59
1.3
1.2
—
5.21
—
0
26
6
35
1.67
0.57
1.0
1.2
—
—
—
0
0
52
592
0.84
0.55
1.3
1.3
13.08
15.48
iu/ml
0.25
11
112
8
121
0.64
0.55
1.3
1.2
—
—
—
0
0
6
37
1.58
0.54
1.0
1.1
—
—
—
0
0
9
62
1.42
0.52
1.7
2.1
—
—
—
0
0
13
89
1.43
0.51
3.0
1.7
—
—
—
0
0
18
132
1.34
0.50
4.3
2.5
—
—
—
0
0
12
82
1.43
0.48
1.8
1.4
—
—
—
0
0
7
47
1.45
0.46
1.3
1.7
8.41
6.93
mmol/l
—
7
42
20
151
1.30
0.46
1.9
1.9
—
—
—
0
0
50
558
0.86
0.44
1.2
1.2
0.99
4.32
u/ml
1.86
19
182
5
30
1.62
0.43
1.0
2.4
0.00
0.15
g/l
—
5
30
5
30
1.62
0.43
1.0
2.4
0.00
0.00
g/l
—
5
30
28
224
1.23
0.42
1.0
1.0
9.02
9.14
mu/l
0.03
22
192
17
209
0.78
0.39
2.1
1.8
—
—
—
0
0
5
34
1.43
0.39
1.0
1.6
—
—
—
0
0
33
373
0.85
0.36
1.4
1.4
—
—
—
0
0
21
248
0.82
0.35
3.5
2.1
—
—
—
0
0
6
41
1.43
0.35
1.0
1.0
2403.67
1572.59
miu/ml
—
6
41
9
120
0.73
0.35
1.7
1.9
—
—
—
0
0
6
45
1.30
0.33
1.3
1.2
—
—
—
0
0
12
150
0.77
0.32
1.2
1.5
52.37
12.67
u/ml
—
7
120
24
273
0.85
0.29
1.5
1.6
61.48
60.97
ug/l
0.02
19
242
8
105
0.74
0.29
1.4
1.3
—
—
—
0
0
8
60
1.30
0.28
1.1
1.3
—
—
—
0
0
8
63
1.24
0.27
1.3
1.3
—
—
—
0
0
78
705
1.09
0.25
1.1
1.1
—
—
—
0
0
231
2169
1.06
0.25
1.7
1.9
0.43
3.57
u/ml
7.56
44
421
6
82
0.71
0.24
1.2
1.4
81.33
79.54
%
—
6
82
37
323
1.12
0.23
1.1
1.1
6.63
12.23
u/ml
0.89
23
216
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
5
41
1.19
0.21
1.0
1.2
—
—
—
0
0
5
41
1.19
0.21
1.0
1.2
—
—
—
0
0
5
41
1.19
0.21
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
13
151
0.83
0.20
1.6
1.1
—
—
—
0
0
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
14
161
0.84
0.20
1.3
1.3
—
—
—
0
0
6
47
1.24
0.20
1.3
1.4
—
—
—
0
0
6
47
1.24
0.20
1.3
1.2
—
—
—
0
0
43
385
1.09
0.18
2.8
1.9
—
35.23
—
0
6
7
60
1.14
0.17
1.1
1.3
—
—
—
0
0
13
148
0.85
0.17
1.6
1.1
—
—
—
0
0
7
61
1.12
0.17
1.1
1.3
—
—
—
0
0
42
378
1.09
0.16
2.8
2.0
171.43
157.12
u/ml
0.12
23
188
94
953
0.95
0.15
2.4
2.3
—
—
—
0
0
7
85
0.80
0.14
1.6
1.5
—
—
—
0
0
38
345
1.08
0.13
1.2
1.1
5.08
7.47
u/ml
0.38
25
239
20
176
1.11
0.12
1.0
1.0
3.07
3.26
kpa
0.17
13
147
22
234
0.91
0.12
1.5
1.5
—
—
—
0
0
23
244
0.91
0.12
1.5
1.5
1.21
1.21
ratio
—
10
147
23
244
0.91
0.12
1.5
1.5
0.95
0.91
ratio
—
10
147
23
244
0.91
0.12
1.5
1.5
1.14
1.18
ratio
—
10
147
30
271
1.08
0.11
1.3
1.5
—
—
—
0
0
107
1071
0.97
0.10
2.8
2.5
—
—
—
0
0
5
44
1.11
0.09
1.0
1.2
—
—
—
0
0
5
44
1.11
0.09
1.0
1.2
—
—
—
0
0
20
179
1.09
0.09
1.0
1.0
-0.80
-2.16
mmol/l
—
6
30
20
179
1.09
0.09
1.0
1.0
7.06
7.46
kpa
0.34
13
149
6
57
1.02
0.08
3.0
2.5
—
—
—
0
0
7
62
1.10
0.08
5.7
3.3
—
—
—
0
0
7
62
1.10
0.08
5.7
3.2
—
—
—
0
0
6
69
0.84
0.07
3.5
3.2
14.83
32.63
u/ml
—
6
59
8
72
1.08
0.07
13.3
10.1
5.30
5.29
pmol/l
—
8
72
8
76
1.02
0.07
1.0
1.0
168.75
164.59
g/l
—
8
76
34
316
1.05
0.06
1.1
1.1
0.57
0.44
u/ml
0.14
21
172
58
548
1.03
0.05
1.2
1.3
3.61
2.51
u/ml
0.34
43
398
46
433
1.04
0.05
1.5
1.3
—
—
—
0
0
33
333
0.96
0.04
1.5
1.3
278.23
235.69
miu/ml
0.25
15
167
11
98
1.09
0.04
1.0
1.4
—
1.51
—
0
10
11
116
0.92
0.04
1.2
1.4
—
33.73
—
0
18
11
116
0.92
0.04
1.1
1.4
—
7.30
—
0
13
53
503
1.03
0.03
1.1
1.3
1.38
1.12
u/ml
0.14
37
357
53
506
1.02
0.02
1.1
1.3
4.40
7.42
u/ml
0.99
37
393
13
120
1.05
0.01
2.7
3.4
135.00
137.59
g/l
0.20
13
105
55
541
0.99
0.01
3.0
2.6
7591.77
5695.43
u/l
0.12
13
196
36
355
0.98
0.00
1.6
1.8
—
—
—
0
0
20
196
0.99
0.00
1.4
1.5
19.50
12.27
u/ml
0.14
14
131
51
496
1.00
0.00
1.1
1.2
4.29
2.90
u/ml
0.34
39
367
12
120
0.97
0.00
1.1
1.3
—
37.29
—
0
8
119
1156
1.00
0.00
3.4
3.7
87.34
111.08
ug/g
0.64
97
942
10
99
0.98
0.00
1.5
1.3
0.41
0.46
ug/l
—
5
21
0
9
0.00
0.00
0.0
2.4
—
2.91
—
0
9
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
1.19
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
1.29
—
0
8
0
7
0.00
-0.00
0.0
5.6
—
159.71
—
0
7
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
6
59
0.99
-0.00
1.2
1.3
—
—
—
0
0
6
66
0.88
-0.00
1.3
1.1
—
—
—
0
0
5
56
0.87
-0.00
1.2
1.8
8.18
7.19
mmol/l
—
5
56
6
60
0.97
-0.00
1.2
1.3
—
—
—
0
0
6
60
0.97
-0.00
1.0
1.1
29.35
35.82
iu/ml
—
6
60
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_MOTOR – Specific developmental disorder of motor function
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).